Aceragen, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and rheumatic diseases in the United States.
Aceragen stock last closed at $1.62, down 1.82% from the previous day, and has decreased 85.39% in one year. It has underperformed other stocks in the Biotechnology industry by 0.71 percentage points. Aceragen stock is currently +23.66% from its 52-week low of $1.31, and -89.88% from its 52-week high of $16.00.
As of Jun 8, 2023, there are 8.42M ACGN shares outstanding. The market capitalization of ACGN is $13.65M. In the past 24 hours, 10,473 ACGN shares were traded.
You need an online brokerage account to access the NASDAQ market and buy ACGN stock.
Based on our analysis, eToro is the best stock brokerage. Here's why:
Get $10 towards your stock purchase by opening an account with eToro today.Open eToro Account
Now that you've picked your brokerage, it's time to fill out some personal details so you are able to buy ACGN stock today.
Now that you have opened your account on the highest rated stock app, you can securely and quickly fund your account:
Watch the walkthrough below for more details transferring funds into your brokerage account.
After you have figured out the best place to buy Aceragen stock, it's very important to research their stock prior to investing, so you truly understand the risk as well as the upside.
WallStreetZen was built to help average investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ACGN's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge ACGN's true value.
Using relative valuations metrics:
You can do more valuation research on ACGN's stock here.
Last year, ACGN revenue was $0.00. Over the last 5 year, ACGN's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 91.4%.
Dig into ACGN's earnings and revenue performance here.
In the past 12 months, insiders at ACGN have bought more shares than they have sold.
Atul Chopra, 10% Owner of ACGN, was the latest ACGN insider to sell. They sold $2,109.80 worth of ACGN stock on May 17, 2023.
Get more info about who owns ACGN stock here.
No, Aceragen doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two primary order types:
Press the Open button and eToro will execute your order.
If you want additional info about investing in stocks on eToro, watch the how to video below:
Now that you own some shares in ACGN, you'll want to keep up with your new shares.
Add ACGN to a watchlist to get notified of the latest news about your ACGN stock.
To summarize, here are the 6 steps to buy stock in Aceragen:
If you require a brokerage, eToro is our recommended option.Get Started with eToro Today
If you want to keep an eye on your investment in Aceragen, add ACGN to your watchlist below.
How much does it cost to buy one Aceragen share?
What is the best way to buy Aceragen stock?